479 related articles for article (PubMed ID: 28536774)
21. Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults.
Li GF; Zheng QS; Yu Y; Zhong W; Zhou HH; Qiu F; Wang G; Yu G; Derendorf H
Clin Pharmacokinet; 2019 Jul; 58(7):927-941. PubMed ID: 30767128
[TBL] [Abstract][Full Text] [Related]
22. Application of a physiologically based pharmacokinetic model for the prediction of mirabegron plasma concentrations in a population with severe renal impairment.
Konishi K; Minematsu T; Nagasaka Y; Tabata K
Biopharm Drug Dispos; 2019 May; 40(5-6):176-187. PubMed ID: 30985942
[TBL] [Abstract][Full Text] [Related]
23. The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction.
Swan SK; Hursting MJ
Pharmacotherapy; 2000 Mar; 20(3):318-29. PubMed ID: 10730687
[TBL] [Abstract][Full Text] [Related]
24. A GFR-Based Method to Predict the Effect of Renal Impairment on the Exposure or Clearance of Renally Excreted Drugs: A Comparative Study Between a Simple GFR Method and a Physiologically Based Pharmacokinetic Model.
Mahmood I
Drugs R D; 2020 Dec; 20(4):377-387. PubMed ID: 33150526
[TBL] [Abstract][Full Text] [Related]
25. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
[TBL] [Abstract][Full Text] [Related]
26. Applications of Physiologically Based Pharmacokinetic Modeling of Rivaroxaban-Renal and Hepatic Impairment and Drug-Drug Interaction Potential.
Willmann S; Coboeken K; Kapsa S; Thelen K; Mundhenke M; Fischer K; Hügl B; Mück W
J Clin Pharmacol; 2021 May; 61(5):656-665. PubMed ID: 33205449
[TBL] [Abstract][Full Text] [Related]
27. Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation.
Polasek TM; Tucker GT; Sorich MJ; Wiese MD; Mohan T; Rostami-Hodjegan A; Korprasertthaworn P; Perera V; Rowland A
Br J Clin Pharmacol; 2018 Mar; 84(3):462-476. PubMed ID: 29194718
[TBL] [Abstract][Full Text] [Related]
28. Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions.
Huang W; Nakano M; Sager J; Ragueneau-Majlessi I; Isoherranen N
Drug Metab Dispos; 2017 Nov; 45(11):1156-1165. PubMed ID: 28860113
[TBL] [Abstract][Full Text] [Related]
29. A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.
Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO
Eur J Clin Pharmacol; 2017 Aug; 73(8):981-990. PubMed ID: 28451709
[TBL] [Abstract][Full Text] [Related]
30. Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults.
Diestelhorst C; Boos J; McCune JS; Russell J; Kangarloo SB; Hempel G
Cancer Chemother Pharmacol; 2013 Nov; 72(5):991-1000. PubMed ID: 24061863
[TBL] [Abstract][Full Text] [Related]
31. A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug-Drug-Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals.
Hanke N; Türk D; Selzer D; Ishiguro N; Ebner T; Wiebe S; Müller F; Stopfer P; Nock V; Lehr T
Clin Pharmacokinet; 2020 Nov; 59(11):1419-1431. PubMed ID: 32449077
[TBL] [Abstract][Full Text] [Related]
32. Development of a Physiologically Based Pharmacokinetic Model for Prediction of Pramipexole Pharmacokinetics in Parkinson's Disease Patients With Renal Impairment.
You X; Wu W; Xu J; Jiao Z; Ke M; Huang P; Lin C
J Clin Pharmacol; 2020 Aug; 60(8):999-1010. PubMed ID: 32090332
[TBL] [Abstract][Full Text] [Related]
33. Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.
Burt HJ; Neuhoff S; Almond L; Gaohua L; Harwood MD; Jamei M; Rostami-Hodjegan A; Tucker GT; Rowland-Yeo K
Eur J Pharm Sci; 2016 Jun; 88():70-82. PubMed ID: 27019345
[TBL] [Abstract][Full Text] [Related]
34. Physiologically based pharmacokinetic modeling of levetiracetam to predict the exposure in hepatic and renal impairment and elderly populations.
Shen C; Shao W; Wang W; Sun H; Wang X; Geng K; Wang X; Xie H
CPT Pharmacometrics Syst Pharmacol; 2023 Jul; 12(7):1001-1015. PubMed ID: 37170680
[TBL] [Abstract][Full Text] [Related]
35. Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects.
Cui C; Valerie Sia JE; Tu S; Li X; Dong Z; Yu Z; Yao X; Hatley O; Li H; Liu D
Br J Clin Pharmacol; 2021 Jul; 87(7):2711-2722. PubMed ID: 33068053
[TBL] [Abstract][Full Text] [Related]
36. Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
Colbers A; Greupink R; Litjens C; Burger D; Russel FG
Clin Pharmacokinet; 2016 Mar; 55(3):381-96. PubMed ID: 26369773
[TBL] [Abstract][Full Text] [Related]
37. Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions.
Ono C; Hsyu PH; Abbas R; Loi CM; Yamazaki S
Drug Metab Dispos; 2017 Apr; 45(4):390-398. PubMed ID: 28167538
[TBL] [Abstract][Full Text] [Related]
38. Physiologically Based Pharmacokinetic Modelling of Glycopyrronium in Patients With Renal Impairment.
Higashimori M; Ishikawa K; Gillen M; Zhou D
J Pharm Sci; 2021 Jan; 110(1):438-445. PubMed ID: 32240691
[TBL] [Abstract][Full Text] [Related]
39. Development of a physiologically based model for oseltamivir and simulation of pharmacokinetics in neonates and infants.
Parrott N; Davies B; Hoffmann G; Koerner A; Lave T; Prinssen E; Theogaraj E; Singer T
Clin Pharmacokinet; 2011 Sep; 50(9):613-23. PubMed ID: 21827216
[TBL] [Abstract][Full Text] [Related]
40. A novel strategy for physiologically based predictions of human pharmacokinetics.
Jones HM; Parrott N; Jorga K; Lavé T
Clin Pharmacokinet; 2006; 45(5):511-42. PubMed ID: 16640456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
